Skip to content
10-K

Annual Report

GFR PHARMACEUTICALS INC

0001437749-13-003698

← back to feed
Filed
Mar 29, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 25, 2013 42.08M sh
Capex FY 2012 · Dec 31, 2012 $7.22K
Capex FY 2012 · Dec 31, 2011 $306.44K
Capex FY 2012 · Jun 21, 2011 $4.33M
Operating Cash Flow FY 2012 · Dec 31, 2012 $1.2M
Operating Cash Flow FY 2012 · Dec 31, 2011 $480.96K
Cash And Equivalents FY 2012 · Dec 31, 2012 $564.55K
Cash And Equivalents FY 2012 · Dec 31, 2011 $460.88K
Cash And Equivalents FY 2012 · Dec 31, 2010 $300.72K
Stockholders Equity FY 2012 · Dec 31, 2012 $9.83M
Stockholders Equity FY 2012 · Dec 31, 2011 $8.52M
Current Liabilities FY 2012 · Dec 31, 2012 $739.53K
Current Liabilities FY 2012 · Dec 31, 2011 $2.28M
Total Liabilities FY 2012 · Dec 31, 2012 $1.59M
Total Liabilities FY 2012 · Dec 31, 2011 $3.12M
Current Assets FY 2012 · Dec 31, 2012 $1.43M
Current Assets FY 2012 · Dec 31, 2011 $1.09M
Total Assets FY 2012 · Dec 31, 2012 $12.17M
Total Assets FY 2012 · Dec 31, 2011 $12.33M
Sga Expense FY 2012 · Dec 31, 2012 $786.03K
Sga Expense FY 2012 · Dec 31, 2011 $680.57K
Rd Expense FY 2012 · Dec 31, 2012 $103.14K
Rd Expense FY 2012 · Dec 31, 2011 $29.15K
Net Income FY 2012 · Dec 31, 2012 $1.28M
Net Income FY 2012 · Dec 31, 2011 $1.97M
Operating Income FY 2012 · Dec 31, 2012 $1.79M
Operating Income FY 2012 · Dec 31, 2011 $2.73M
Gross Profit FY 2012 · Dec 31, 2012 $2.77M
Gross Profit FY 2012 · Dec 31, 2011 $3.45M
Cost Of Revenue FY 2012 · Dec 31, 2012 $1.5M
Cost Of Revenue FY 2012 · Dec 31, 2011 $1.22M